US Sues Gilead, Alleging PrEP Drugs Infringe on HHS Patents

On behalf of the Department of Health and Human Services (HHS), the United States recently sued Gilead Sciences and Gilead Sciences Ireland over their preexposure prophylaxis (PrEP) drugs.

Read the full article here

Related Articles